UK, with partners, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate. To date, more than 100,000 individuals have been vaccinated with a Janssen AdVac®-based vaccine.

Dr. Lisa Cassis, UK’s vice president for research, oversees the university’s vast medical and nonmedical research efforts. On this episode of "Behind the Blue," she discusses the many areas UK's Office of Research is prioritizing, including greater diversity and inclusion, the increasing commitment to opportunities for undergraduate research, returning research efforts to higher capacity during the COVID-19 pandemic, and more.

Ophthalmologist Ana Bastos de Carvalho has leveraged UK’s Physician Scientist Training Program to improve a network of telemedicine eye screenings for Kentuckians with diabetes in underserved communities.